Marcin Skrzypski
Gdansk, PM, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.
Journal: Frontiers in immunology
Published: December 08, 2025
Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.
Journal: ESMO open
Published: May 27, 2025
Chemotherapy-Mediated Complications of Wound Healing: An Understudied Side Effect.
Journal: Advances in wound care
Published: January 06, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Journal: Nature communications
Published: September 12, 2023
Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
Journal: Translational lung cancer research
Published: October 12, 2022
Body composition and lung cancer-associated cachexia in TRACERx.
Journal: Nature medicine
Published: April 20, 2022
Publisher Correction: A clonal expression biomarker associates with lung cancer mortality.
Journal: Nature medicine
Published: June 05, 2020
Cancer cachexia in thoracic malignancy: a narrative review.
Journal: Current opinion in supportive and palliative care
Published: October 09, 2019
A clonal expression biomarker associates with lung cancer mortality.
Journal: Nature medicine
Published: November 12, 2018
Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer.
Journal: Cancer treatment reviews
Published: February 20, 2018
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 01, 2017
Last Updated: 09/26/2026